News 06.02.2020 Research & Development: Abicipar in Neovascular Wet Age-Related Macular Degeneration: Two-year results from CEDAR and SEQUOIA presented at AAO in October 2019 demonstrate that vision gains observed after one year with both, every 8-week and every 12-week dosing were maintained in second year FDA and EMA filings accepted and under...
News 30.01.2020 Schlieren (Zurich), Switzerland, January 30, 2020 – Kuros Biosciences (SIX: KURN) today announced the publication of data from a clinically-relevant preclinical model comparing MagnetOs with autologous bone, Vitoss® BA2X (Stryker Corp.) and Novabone Putty® (Novabone Products, LLC) in instrumented posterolateral spinal fusion in sheep. Utilizing multiple assessments for fusion, the study...
Internal events
Event date: 25.02.2020
WHEN: 25 February 2020 09:00 - 12:00
WHERE: Bio-Technopark Auditorium, Wagistrasse 25, Schlieren-Zurich
In preparation for the second Redefining Early Stage Investments (RESI) conference to be held in Europe, Life Science Nation and Venture Valuation are offering Tech Hubs around Europe a Bootcamp addressing key topics for early-stage life science companies.
Program and...
Internal events
Event date: 26.03.2020
During a 30 minutes IP coaching from Dr. Peter Steinecke, German and European Patent Attorney from WJS , you will have the opportunity to discuss challenges to turn your innovation to a patentable invention and establish Intellectual Property (IP) for your company. In addition, you may ask for advice how...
Internal events
Event date: 04.02.2020
Bio-Technopark Schlieren-Zürich and Euronext are delighted to invite you to a discussion on different financing perspectives and opportunities, followed by a podium discussion taking place on Tuesday 4 February 2020 from 16:00 to 18:00, Auditorium Wagistrasse 25.
More information and registration